Literature DB >> 7530707

Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep.

H Morisaki1, F Bloos, J Keys, C Martin, A Neal, W J Sibbald.   

Abstract

We tested the hypothesis that the type of fluid infused to chronically maintain intravascular volumes would modify both microvascular integrity and cellular structure in extrapulmonary organs in hyperdynamic sepsis. After cecal ligation and perforation, awake sheep were treated for 48 h with 10% pentastarch (n = 9), 10% pentafraction (Du Pont Critical Care; n = 8), or Ringer lactate (n = 8) titrated to maintain a constant left atrial pressure. After 48 h of fluid therapy, biopsy samples were taken from the left ventricle and gastrocnemius for electron microscopy. At this time, all groups demonstrated a similar hyperdynamic circulatory response, increased systemic O2 utilization and organ blood flows, measured by radioactive microsphere injection. However, greater capillary luminal areas with less endothelial swelling and less parenchymal injury were found in septic sheep treated with pentastarch vs. Ringer lactate infusion in both muscle types. Pentafraction showed few benefits in study end points over pentastarch. Thus, we conclude that chronic intravascular volume resuscitation of hyperdynamic sepsis with pentastarch ameliorated the progression of both microvascular and parenchymal injury. These findings indicate that microvascular surface area for tissue O2 exchange in sepsis may be better preserved with chronically infused colloid, resulting in less parenchymal injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7530707     DOI: 10.1152/jappl.1994.77.3.1507

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

1.  Fluid resuscitation during capillary leakage: does the type of fluid make a difference.

Authors:  Walter R Hasibeder
Journal:  Intensive Care Med       Date:  2002-03-27       Impact factor: 17.440

2.  Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial.

Authors:  A Dave Nagpal; Andrea Cowan; Linna Li; Graeme Nusca; Linrui Guo; Richard J Novick; Chris C Harle; Andrew A House; Stephanie Fox; Philip M Jones
Journal:  Can J Kidney Health Dis       Date:  2020-07-28

3.  Effects of fluid challenge on gastric mucosal PCO2 in septic patients.

Authors:  Eliézer Silva; Daniel De Backer; Jacques Creteur; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

4.  Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients.

Authors:  Franziska Schabinski; Janaina Oishi; Fabio Tuche; Alain Luy; Yasser Sakr; Donald Bredle; Christiane Hartog; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

5.  Clinical strategies for supporting the untransfusable hemorrhaging patient.

Authors:  Gavin M Melmed; Meredith E Hulsey; Mike Newhouse; Houston E Holmes; Edward J Mays
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-10

6.  Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery.

Authors:  Joachim Boldt; Michael Ducke; Bernhard Kumle; Michael Papsdorf; Ernst-Ludwig Zurmeyer
Journal:  Intensive Care Med       Date:  2004-01-08       Impact factor: 17.440

7.  An alternative pathway for preclinical research in fluid management.

Authors:  W J Sibbald
Journal:  Crit Care       Date:  2000-10-13       Impact factor: 9.097

8.  Neutrophil Elastase Inhibition Ameliorates Endotoxin-induced Myocardial Injury Accompanying Degradation of Cardiac Capillary Glycocalyx.

Authors:  Tetsuya Fukuta; Hideshi Okada; Genzou Takemura; Kodai Suzuki; Chihiro Takada; Hiroyuki Tomita; Akio Suzuki; Kazumasa Oda; Akihiro Uchida; Saori Matsuo; Hirotsugu Fukuda; Hirohisa Yano; Isamu Muraki; Ryogen Zaikokuji; Ayumi Kuroda; Ayane Nishio; So Sampei; Nagisa Miyazaki; Yasuaki Hotta; Noriaki Yamada; Takatomo Watanabe; Kentaro Morishita; Tomoaki Doi; Takahiro Yoshida; Hiroaki Ushikoshi; Shozo Yoshida; Yoichi Maekawa; Shinji Ogura
Journal:  Shock       Date:  2020-09       Impact factor: 3.533

Review 9.  Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis.

Authors:  Takeshi Suzuki; Yuta Suzuki; Jun Okuda; Takuya Kurazumi; Tomohiro Suhara; Tomomi Ueda; Hiromasa Nagata; Hiroshi Morisaki
Journal:  J Intensive Care       Date:  2017-03-03

10.  Fluids in septic shock: too much of a good thing?

Authors:  A B Johan Groeneveld
Journal:  Crit Care       Date:  2010-01-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.